Reducing radiation exposure using KARL100: the experience of the Royal Free London Nuclear Medicine Department

With more than 140 installations, today KARL100 can be taken as a technology landmark to reduce radiation exposure in Nuclear Medicine departments.


 

One of the reasons why we’ve been experiencing a growing trend of requests from clinics, for their PET/CT wards, is certainly KARL100’s effectiveness in reducing radiation exposure for both operators and patients.

This is certainly the case for one of the very first centres in Europe to choose KARL100 and Rad-Inject, the Royal free London NHS Foundation Trust, where the installation came with a interesting study, which is still a very current topic, aimed at evaluating and confirming the decrease of the levels of exposure to radiations while using KARL100.

 

 

Some years later we came back to the Nuclear Medicine ward of the Royal Free to have a chat about their user experience.

 

Read more about the Royal Free experience on the site of our partner LabLogic

For details

Posted in Nuclear Medicine
© 2021 TEMA SINERGIE S.p.A
Fiscal Code n. 00970310397
Business Register of Ravenna n. 00970310397  |  R.E.A. 111877
Capital Stock € 2.000.000,00 paid-up